Hanan Enterprise Memories IQ Capsules
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-alpha,16-alpha-Apovincaminic acid ethyl ester Source : Vinpocetine | 7 milligramme | Not calculated |
| Phosphore Source : Phosphate de calcium, dibasique | 33 milligramme | 99,000 µg |
| Phosphore Source : Dihydrate | 33 milligramme | 99,000 µg |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| 1-Propanaminium, 2-(acétyloxy)-3-carboxy-N,N,N-triméthyl-, chlorure, (R)- Source : N-acétyl L-chlorhydrate de carnitine | 167 microgrammes | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 20:1 Dry plant equivalent : 1,000 milligramme Potency : 24 % Flavonoid glycosides | 20 milligramme | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzine A | 20 microgrammes | Not calculated |
| Hericium erinaceus Source : Corps fructifère | 100 milligramme | Not calculated |
| Bacopa monnieri Source : Feuille | 67 milligramme | Not calculated |
| Phosphatidylsérine Source : Enriched soy lecithin | 33 milligramme | Not calculated |
| Centella asiatica Source : Feuille | 33 milligramme | Not calculated |
| Piper nigrum Source : Fruit | 0.67 milligramme | Not calculated |
| N,N-diméthyl-2-hydroxyéthylamine Source : Deanol | 100 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are taking any other medications or natural health products, consult a health care practitioner prior to use, as black pepper/piperine may alter their effectiveness. If you are taking cholinergic or anticholiergic drugs, or medications for diabetes, high blood pressure, seizures, consult a health care practitioner prior to use. If you have a psychiatric or neurological disorder such as, but not limited to, depression, schizophrenia, dementia, Parkinson's, effective disorder, or a seizure disorder such as epilepsy, consult a health care practitioner. If you have low or high blood pressure, cardiac arrhythmia, or have suffered a stroke, consult a health care practitioner prior to use. If you have a history of alcohol abuse, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are pregnant or breastfeeding, or if you have a liver or kidney disease. Do not use if you are taking health care products that effect blood coagulations (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oil, vitamin E) as this may increase the risk of spontaneous bleeding.
Product record
- Licence holder
- Hanan Enterprise
- NPN or DIN-HM
- 80069938
- Status
- Inactive licence
- Licence date
- 3 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80069938
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ginkgo biloba
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
- Phosphatidylsérine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Hanan Enterprise Memories IQ Capsules”, https://compoatlas.com/en/supplements/canada/80069938-hanan-enterprise-memories-iq-capsules, updated 3 June 2016.